tiprankstipranks

Keith Manchester Insider Profile

11 Followers
Keith Manchester, Director at Roivant Sciences, holds 15.44M shares in Roivant Sciences (Ticker: ROIV), holds 46.07K shares in Arbutus Biopharma (Ticker: ABUS). Most recently, Keith Manchester Sold ― shares of Roivant Sciences on Jun 30, 2026 for an estimated value of $56.44M.
tipranks
Keith Manchester

Keith Manchester
Roivant Sciences (ROIV)
Director

Ranked #99,822 out of 108,921 Corporate Insiders

Profitable Transactions

25%
2 out of 8 Profitable Transactions

Average Return

-33.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$539M
99.96%
0.04%
A breakdown of Keith Manchester's holdings

Insider Roles

Roivant Sciences
(ROIV)
Director
Arbutus Biopharma
(ABUS)
Director
Roles that Keith Manchester holds in companies

Most Profitable Insider Trade

Stock:
Arbutus Biopharma
(ABUS)
Rating:Informative Sell
Date:Aug 16, 2024 - Aug 16, 2025
Return:+9.20%
The most profitable trade made by Keith Manchester

Keith Manchester's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Roivant Sciences
Jun 30, 2026
Director
Informative Sell
56.44M
$539.23M
Arbutus Biopharma
Aug 16, 2024
Director
Uninformative Buy
30.75K
$237.26K
List of latest transactions for each holding click on a transaction to see Keith Manchester's performance on stock

Keith Manchester insider profile FAQ

What is the percentage of profitable transactions made by Keith Manchester?
The percentage of profitable transactions made by Keith Manchester is 25%.
    What is the average return per transaction made by Keith Manchester?
    The average return per transaction made by Keith Manchester is -33.50%.
      What stocks does Keith Manchester hold?
      Keith Manchester holds: ROIV, ABUS stocks.
        What was Keith Manchester’s latest transaction?
        Keith Manchester latest transaction was an Informative Sell of $56.44M.
          What was Keith Manchester's most profitable transaction?
          Keith Manchester’s most profitable transaction was an Informative Sell of ABUS stock on August 16, 2024. The return on the trade was 9.20%.
            What is Keith Manchester's role in Roivant Sciences?
            Keith Manchester's role in Roivant Sciences is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.